The pathology underlying frontotemporal lobar degeneration (FTLD) has been defined more clearly in recent years.
1 Clinical and pathological features overlap, such that apparently similar clinical presentations can be due to different histopathological abnormalities. Frontotemporal lobar degeneration also occurs in both familial and sporadic forms, with 10% to 50% of cases being familial.
2 It is not clear whether sporadic disease and familial disease differ in clinical phenotype. Mutations in the
tau gene occur in only half of familial cases.
3 At least 3 different gene loci have been proposed for familial FTLD occurring without tau deposition or tau mutations.
4 An understanding of the similarities or otherwise of familial and sporadic disease will become increasingly important when these genes are identified.